Stay updated on SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Sign up to get notified when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.

Latest updates to the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.3 is shown in the page's revision history, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The study content, eligibility criteria, and results remain unchanged.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page now consolidates study locations under a single Locations section listing Florida, Illinois, Kentucky, and Virginia; separate location sections/pages for these states have been removed.SummaryDifference0.6%

- Check111 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page.SummaryDifference0.1%

Stay in the know with updates to SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPN-812 Safety/Efficacy in Adult ADHD: Clinical Trial page.